Duration of measles vaccination?
Stickl, H.
Münchener Medizinische Wochenschrift 113(19): 743
1971
ISSN/ISBN: 0341-3098 PMID: 5108323 Document Number: 38259
Document emailed within 1 workday
Related Documents
Trier, H.; Rønne, T. 1992: Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella Ugeskrift for Laeger 154(29): 2008-2013Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771
Bjerregaard, P.; Pedersen, K.M.; Kamper-Jørgensen, F.; Koch, C.; Pedersen, F.K.; Wagner, A.L.; Zoffmann, H. 1985: Vaccination against measles, mumps and German measles. II. Socio-economic analysis Ugeskrift for Laeger 147(38): 3017-3022
Colomer Pache, M.; Arnedo Pena, A. 1988: Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination Medicina Clinica 91(17): 649-652
Benn, C.S.; Martins, Cário.L.; Andersen, A.; Fisker, A.B.; Whittle, H.C.; Aaby, P. 2020: Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival Frontiers in Pediatrics 8: 20
Bjerregaard, P.; Pedersen, K.M.; Kamper-Jørgensen, F.; Koch, C.; Pedersen, F.K.; Wagner, A.L.; Zoffmann, H. 1985: Vaccination against measles, mumps and German measles. I. Medical and epidemiological aspects Ugeskrift for Laeger 147(38): 3013-3017
Semba, R.D.; Munasir, Z.; Beeler, J.; Akib, A.; Muhilal; Audet, S.; Sommer, A. 1995: Reduced seroconversion to measles in infants given vitamin A with measles vaccination Lancet 345(8961): 1330-1332
Balé, C.; Garly, M-Lill.; Martins, C.; Nielsen, J.; Whittle, H.; Aaby, P. 2011: Risk factors for measles in young infants in an urban African area with high measles vaccination coverage Pediatric Infectious Disease Journal 30(8): 689-693
Lowther, S.A.; Curriero, F.C.; Kalish, B.T.; Shields, T.M.; Monze, M.; Moss, W.J. 2009: Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey Lancet 373(9668): 1025-1032
Lebart, L.; Péquignot, H.; Rosch, G. 1970: Public health policy. Smallpox vaccination in the USA, and measles vaccination in Senegal La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 46(42): 2672-2677
Alberti, K.P.; King, L.A.; Burny, M-Eve.; Ilunga, B.Kebela.; Grais, R.F. 2010: Reactive vaccination as an effective tool for measles outbreak control in measles mortality reduction settings, Democratic Republic of Congo, 2005-2006 International health 2(1): 65-68
Bernhardt, G.L.; Cameron, N.A.; Willems, B.; Boulle, A.; Coetzee, D. 2013: Measles vaccination coverage in high-incidence areas of the Western Cape, following the mass vaccination campaign South African Medical Journal 103(3): 181-186
Goodson, J.L.; Kulkarni, M.A.; Vanden Eng, J.L.; Wannemuehler, K.A.; Cotte, A.H.; Desrochers, R.E.; Randriamanalina, B.; Luman, E.T. 2012: Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar Tropical Medicine and International Health: Tm and Ih 17(4): 430-437
Farizo, K.M.; Stehr-Green, P.A.; Markowitz, L.E.; Patriarca, P.A. 1992: Vaccination levels and missed opportunities for measles vaccination: a record audit in a public pediatric clinic Pediatrics 89(4 Part 1): 589-592
Schmöger, R.; Becker, H.; Enders-Ruckle, G. 1971: Combination vaccination in children's homes with regard to measles vaccination Medizinische Klinik 66(6): 194-198
Tohme, R.A.; François, J.; Wannemuehler, K.; Magloire, R.; Danovaro-Holliday, M.Carolina.; Flannery, B.; Cavallaro, K.F.; Fitter, D.L.; Purcell, N.; Dismer, A.; Tappero, J.W.; Vertefeuille, J.F.; Hyde, T.B. 2014: Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination Tropical Medicine and International Health: Tm and Ih 19(9): 1105-1115
Muntiu, N.; Dumitrescu, A.; Dohotaru, V.; Negrutiu, T.; Bercan, A.; Mircescu, G.; Stirbu, C.; Tomescu, A. 1972: Duration of post-vaccination immunity against foot-and-mouth disease in relation to animal age, vaccine dose and vaccination repetition (recurrence effect) Bulletin - Office International des Epizooties 77(5): 771-787
Babakura, B.; Nomhwange, T.; Jean Baptiste, A.E.; Dede, O.; Taiwo, L.; Abba, S.; Soyemi, M.; Idowu, A.M.; Terna Richard, M.; Braka, F.; Oteri, J.; Shuaib, F. 2021: The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: a case study of 2017/18 measles campaign in Borno state, Nigeria Vaccine 39(Suppl 3): C66-C75
Arambepola, R.; Yang, Y.; Hutchinson, K.; Mwansa, F.D.; Doherty, J.A.; Bwalya, F.; Ndubani, P.; Musukwa, G.; Moss, W.J.; Wesolowski, A.; Mutembo, S. 2021: Using geospatial models to map zero-dose children: factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia Bmj Global Health 6(12)
Bolotovskiĭ, V.M.; Gelikman, B.G.; Auzinia, A.V.; Glinskaia, E.V. 1990: The duration and strength of postvaccinal measles immunity Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 32-37